AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
Mar 11, 2014
32566_dirs_2014-03-11_03915796-a9ac-4e43-8ae3-f3379f79e23b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-03-07
Reporting Person: HENDERSON JOHN T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-07 | Common Stock | M | 20000.0 | $7.6 | Acquired | 24000 | Direct |
| 2014-03-07 | Common Stock | S | 20000.0 | $37.8598 | Disposed | 4000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-07 | Non-Qualified Stock Option (right to buy) | $7.6 | M | 20000.0 | Disposed | 2016-01-06 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 300 | Indirect |
Footnotes
F1: One third vests annually beginning on the 1st anniversary of the option date.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2